FierceBiotech Jun 8, 2026 Incyte inks $2B deal to add Star unit to late-phase constellation and challenge Takeda
FierceBiotech Jun 8, 2026 GSK pledges £44.5M in near-term for UK biotech to explore cause of liver fibrosis regression
FierceBiotech Jun 8, 2026 How Unlearn is building a scientific intelligence layer for clinical development
Roche Media Jun 8, 2026 Roche signs $2.3bn blood cancer drug agreement with Nurix Therapeutics - Pharmaceutical Technology